Novavax, Inc.
NVAX
$9.03
$0.556.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -64.11% | 654.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -64.11% | 654.89% | |||
| Cost of Revenue | -22.08% | -13.82% | |||
| Gross Profit | -71.80% | 1,902.38% | |||
| SG&A Expenses | 11.95% | -35.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.33% | -29.54% | |||
| Operating Income | -79.52% | 511.23% | |||
| Income Before Tax | -79.33% | 806.49% | |||
| Income Tax Expenses | -21.17% | -83.89% | |||
| Earnings from Continuing Operations | -79.46% | 740.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -79.46% | 740.07% | |||
| EBIT | -79.52% | 511.23% | |||
| EBITDA | -78.41% | 564.18% | |||
| EPS Basic | -79.59% | 736.82% | |||
| Normalized Basic EPS | -79.51% | 531.68% | |||
| EPS Diluted | -79.01% | 680.32% | |||
| Normalized Diluted EPS | -79.34% | 491.39% | |||
| Average Basic Shares Outstanding | 0.60% | 0.50% | |||
| Average Diluted Shares Outstanding | -0.23% | 10.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||